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G E N E T I C S
Sexual dimorphism in the meiotic requirement 
for PRDM9: A mammalian evolutionary safeguard
Natalie R. Powers, Beth L. Dumont, Chihiro Emori, Raman Akinyanju Lawal, Catherine Brunton, 
Kenneth Paigen, Mary Ann Handel, Ewelina Bolcun-Filas, Petko M. Petkov, Tanmoy Bhattacharyya*
In many mammals, genomic sites for recombination are determined by the histone methyltransferase PRMD9. 
Some mouse strains lacking PRDM9 are infertile, but instances of fertility or semifertility in the absence of PRDM9 
have been reported in mice, canines, and a human female. Such findings raise the question of how the loss of 
PRDM9 is circumvented to maintain fertility. We show that genetic background and sex-specific modifiers can 
obviate the requirement for PRDM9 in mice. Specifically, the meiotic DNA damage checkpoint protein CHK2 acts 
as a modifier allowing female-specific fertility in the absence of PRDM9. We also report that, in the absence of 
PRDM9, a PRDM9-independent recombination system is compatible with female meiosis and fertility, suggesting 
sex-specific regulation of meiotic recombination, a finding with implications for speciation.
INTRODUCTION
Meiotic recombination generates genetic diversity and ensures the 
accuracy of chromosome transmission to the next generation. In many 
organisms, recombination occurs preferentially at sites in the genome 
known as recombination hotspots (1). In a subset of mammals, in-
cluding mice and humans, the positions of hotspots are determined 
by the specialized histone methyltransferase PRDM9—a meiosis- 
specific, DNA binding zinc finger protein that uniquely trimethyl-
ates both lysines 4 and 36 of histone H3 (2–6). This H3K4me3/
H3K36me3 double-positive signature is thought to preferentially 
facilitate recombination at these sites, to the exclusion of other func-
tional elements (1, 6, 7). In the absence of PRDM9, meiotic double- 
strand breaks (DSBs) occur in normal numbers but are localized to 
functional elements enriched for H3K4me3, such as promoters (7). 
In Prdm9-deficient C57BL/6 mice (henceforth B6.Prdm9−/−), repair 
of these ectopic DSBs is impaired, leading to prophase I meiotic ar-
rest of both male and female germ cells, with consequent infertility 
(8). In human males, several point mutations in PRDM9 are associ-
ated with nonobstructive azoospermia (9, 10). Together, these obser-
vations suggest that PRDM9-dependent recombination is required 
for successful reproduction, at least in mice and humans.
However, intriguing exceptions have been reported in both mice 
and a human female. Prdm9-deficient PWD/PhJ (henceforth PWD. 
Prdm9−/−) male mice have a normal meiotic prophase I, although 
they are infertile due to low sperm number (PWD.Prdm9−/− females 
are also infertile) (11). Further, some Prdm9−/− male mice with mixed 
genetic backgrounds are fertile, suggesting background-dependent 
genetic modifiers of the phenotype (11). A report of a single fertile 
PRDM9-null woman shows that PRDM9 can be dispensable for fer-
tility in human females (12). Although Prdm9 is a pseudogene in 
the canine lineage, both male and female canids reproduce success-
fully (13, 14). Together, these findings imply that the requirement 
for PRDM9 in mammalian recombination is complex.
These findings also suggest that a functional Prdm9-independent 
recombination initiation pathway must exist even in species using 
PRDM9; elucidating its mechanisms will help decipher the genetic 
complexity that is likely involved. In male mice, recombination 
hotspots on autosomes are PRDM9-dependent, but the recombina-
tion hotspots within the pseudoautosomal region of the sex chro-
mosomes are activated by a PRDM9-independent recombination 
initiation pathway (7). This suggests that both PRDM9-dependent 
and PRDM9-independent recombination pathways are active in 
tandem during mammalian meiosis and might fulfill functions nec-
essary to bypass reproductive bottlenecks due to dysfunctional or 
absent PRDM9. Although a PRDM9-independent recombination 
mechanism exists in male mice, it has been unknown whether a 
similar pathway functions in females. In this study, we investigated 
oogenesis and the effect of genetic background to determine (i) 
whether there is a sex-specific requirement for PRDM9-dependent 
hotspot activation and (ii) the possible mechanisms allowing organ-
isms to circumvent the loss of PRDM9 and maintain fertility.
RESULTS
Sex-specific requirement for PRDM9-dependent histone 
methyltransferase activity in mice
We used CRISPR-Cas9 gene editing to create a point mutation in 
the PR/SET domain of Prdm9 (Glu365Pro, henceforth Prdm9EP) in 
C57BL/6J (B6) mice (fig. S1, A and B). To determine the effect of 
this mutation, we performed chromatin immunoprecipitation with 
massively parallel DNA sequencing (ChIP-seq) for H3K4me3 and 
the recombinase protein DMC1 (DNA Meiotic Recombinase 1) that 
binds specifically to the single- stranded ends of resected meiotic DSBs 
(Fig. 1, A and B, and fig. S1, C to F), on B6 and B6.Prdm9EP/EP spermato-
cytes. We defined hotspots as PRDM9-dependent H3K4me3 sites 
in the B6 genetic background based on a previously published study 
from our lab (15) (see Materials and Methods for details) and com-
pared the number and distribution of H3K4me3 and DMC1 peaks in 
B6.Prdm9EP/EP spermatocytes to those in wild-type B6 spermatocytes.
We found the Prdm9EP mutation to be a catalytic hypomorph, as 
it severely reduced but did not entirely abolish the methyltransfer-
ase activity of Prdm9 in vivo. The mutation did not affect Prdm9 
expression (fig. S1B) but altered the epigenetic landscape at hotspots 
markedly. In marked contrast to B6 spermatocytes, most hotspots 
in B6.Prdm9EP/EP spermatocytes lacked a detectable H3K4me3 
peak, although residual H3K4me3 enrichment was present at stron-
ger hotspots (Fig. 1, A and B). Quantitatively, there was a fivefold 
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reduction in the number of detectable Prdm9-dependent H3K4me3 
peaks in spermatocytes from B6.Prdm9EP/EP males (Fig. 1, C and D), 
compared to B6 spermatocytes. The intensity of detectable PRDM9- 
dependent peaks was also sharply reduced relative to B6 (Fig. 1E); 
the mean normalized read count at these peaks (n = 3703) was re-
duced more than threefold to 1.29 reads per million (RPM), compared 
to 4.45 RPM in B6 (P = 1.5 × 10−268, Student’s t test). PRDM9- 
dependent H3K4me3 signal was so low overall in B6.Prdm9EP/EP 
Fig. 1. Prdm9EP alters the Prdm9-dependent H3K4me3 and meiotic DSB landscape in spermatocytes. (A and B) Genome browser snapshots of H3K4me3 and DMC1 
ChIP-seq peaks in wild-type and Prdm9EP/EP (Glu365Pro mutation) spermatocytes. (A) One strong and one weaker PRDM9-dependent hotspot are shown, together with one 
PRDM9-independent H3K4me3 peak. (B) Several PRDM9-dependent and PRDM9-independent H3K4me3 peaks are shown. Note the shift in DMC1 peaks to PRDM9-inde-
pendent H3K4me3 peaks in Prdm9EP/EP spermatocytes. (C) Venn diagrams showing the number of detectable PRDM9-dependent H3K4me3 peaks in wild-type (B6) and 
Prdm9EP/EP spermatocytes. (D) Venn diagram directly comparing the number of detectable PRDM9-dependent H3K4me3 peaks in wild-type and Prdm9EP/EP spermatocytes. 
(E) MA plot comparing Prdm9EP/EP versus wild-type signal at PRDM9-dependent H3K4me3 peaks that were detectable in Prdm9EP/EP spermatocytes (n = 3703). (F) Aggre-
gation plot showing normalized average signal intensity [reads per million (RPM)] at known PRDM9-dependent H3K4me3 ChIP-seq peaks (n = 18,838) in wild-type and 
Prdm9EP/EP spermatocytes. (G) Aggregation plot showing normalized average signal intensity (reads per million, RPM) at common nonhotspot H3K4me3 ChIP-seq peaks 
(n = 79,043) in wild-type and Prdm9EP/EP spermatocytes. (H) Distribution of DMC1 peaks in wild-type and Prdm9EP/EP spermatocytes. (I) Venn diagram comparing the 
number of PRDM9-dependent DMC1 peaks in wild-type and Prdm9EP/EP spermatocytes. (J and K) MA plots comparing Prdm9EP/EP versus wild-type DMC1 signal at (J) 
common PRDM9-dependent DMC1 peaks (n = 4724) and (K) common PRDM9-independent DMC1 peaks (n = 378). Black points represent autosomal peaks, and purple 
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spermatocytes that it did not register in aggregation plots of 
H3K4me3 enrichment at all known PRDM9-dependent sites 
(Fig. 1F), confirming a significant alteration in PRDM9-dependent 
methyltransferase activity in B6.Prdm9EP/EP spermatocytes. By con-
trast, PRDM9-independent H3K4me3 peaks (an internal control) 
were unaffected (Fig. 1, A, B, and G), showing that the effect of 
Prdm9EP was restricted to PRDM9-dependent peaks.
The effect of Prdm9EP on the meiotic DSB landscape, as mea-
sured by ChIP-seq for DMC1, was equally marked. A quarter of 
meiotic DSBs occurred at PRDM9-dependent hotspots, while nearly 
three quarters occurred at PRDM9-independent “default” sites, 
which are used exclusively in Prdm9-null spermatocytes (7). This 
was markedly different from B6 spermatocytes, in which about 85% 
of DMC1 peaks occurred at hotspots and only ~4% occurred at de-
fault sites (Fig. 1, A, B, H, and I). These results represented a marked 
improvement over Prdm9-null spermatocytes, which make no DSBs 
at hotspots (7). The average intensity of DMC1 signal at hotspots 
was also reduced in B6.Prdm9EP/EP spermatocytes relative to B6 
spermatocytes: The mean normalized read count at common 
PRDM9-dependent DMC1 peaks (n = 4724) was reduced more 
than threefold to 12.8 RPM, relative to 41.3 RPM in B6 (P = 1.97 × 
10−246, Student’s t test). When DMC1 signals at common peaks be-
tween B6 and B6.Prdm9EP/EP were compared directly, we observed a 
distinct contrast between hotspots and default sites (Fig. 1, J and K). 
While DMC1 signal tended to be higher at default sites in B6. 
Prdm9EP/EP spermatocytes relative to B6 spermatocytes, it was 
much lower at hotspots, especially on the X chromosome (Fig. 1J). 
This likely implies a lower rate of DSB initiation at hotspots in 
B6.Prdm9EP/EP, which would be expected given the drastically re-
duced catalytic activity of PRDM9EP. However, we cannot rule out 
the possibility that DSB repair is affected as well. In summary, the 
residual catalytic activity of Prdm9EP is sufficient to induce DSBs at 
a subset of PRDM9-dependent sites, but not sufficient to rescue 
meiotic arrest, in spermatocytes.
The Prdm9EP mutation also yielded an unanticipated phenotype: 
sexual dimorphism (Fig. 2, A to C, and fig. S1G). Homozygous 
B6.Prdm9EP/EP males exhibited the expected meiotic arrest and in-
fertility, phenocopying both the Prdm9-null condition (8) and a 
recently reported methyltransferase-dead Prdm9 allele (fig. S1G) 
(16, 17). In contrast to the infertile males, all tested homozygous 
B6.Prdm9EP/EP females produced at least one—and up to five— 
litters when mated to B6 males over a period of 6 months (Fig. 2, 
C and D, and tables S1 and S2). The offspring were grossly normal 
and healthy, and those tested, males and females, were fertile. Com-
pared to wild-type B6 controls, ovaries from prepubescent B6. 
Prdm9EP/EP females were smaller but contained all developmental 
stages including primary follicles (Fig. 2, A and B, and fig. S1G). 
Quantification of follicles revealed lower numbers of follicles in 
B6.Prdm9EP/EP ovaries, relative to wild-type and heterozygous ova-
ries (Fig. 2B). B6.Prdm9EP/EP females are therefore subfertile rela-
tive to wild type but escape the unconditional sterility characteristic 
of Prdm9-null B6 females (8).
To determine whether B6.Prdm9EP/EP oocytes exhibit normal 
cytological features of recombination, we performed immunofluo-
rescence staining on meiotic chromatin spreads from the ovaries of 
newborn pups (postnatal day 0 or P0), using antibodies against the cross-
over regulator RNF212 (ring finger protein 212), the crossover marker 
MLH1 (mutL homolog 1), and the synaptonemal complex (SC) 
protein SYCP3 (Fig. 2E). In B6. Prdm9EP/EP, ~65% of pachytene oo-
cytes exhibited homologous synapsis of all chromosomes stained 
with RNF212 and at least one MLH1 focus on each chromosome, 
in comparison to ~91% of B6 pachytene oocytes (Fig. 2E). In dis-
tinct contrast, only ~4% of B6.Prdm9−/− oocytes had all homolo-
gous chromosomes synapsed and with at least one MLH1 focus per 
chromosome (Fig.  2F). Most (~79%) B6.Prdm9−/− pachytene oo-
cytes showed widespread asynapsis and few MLH1 foci on synapsed 
chromosomes (Fig. 2, E and F, and table S3). The average number of 
MLH1 foci was significantly higher in B6.Prdm9EP/EP oocytes than 
in wild-type B6 control oocytes (P = 0.000216, Mann-Whitney U 
test; Fig.  2,  E  and  F, and table S3). Future work will determine 
whether this increase in MLH1 count in B6.Prdm9EP/EP oocytes 
reflects altered crossover rates due to DSBs at a large number of 
PRDM9-independent sites in B6.Prdm9EP/EP oocytes, providing 
both PRDM9-dependent and PRDM9-independent DSB sites as 
candidates for crossover sites, or whether there is some other reason 
for the increase. Together, these results show that the effects of the 
Prdm9EP mutation are tolerated better in female meiosis than in 
male meiosis, with sufficient recombination to ensure at least some 
viable eggs despite the severely reduced catalytic activity. This find-
ing implies that the requirement for PRDM9-dependent hotspot 
activation in mammalian reproduction is subject to sex-specific 
control.
We next investigated whether the absence of an efficient PRDM9- 
dependent hotspot activation mechanism promotes recombination 
at PRDM9-independent sites. To determine where crossover sites 
occur in B6.Prdm9EP/EP females, we used the strategy of outcrossing 
this mutant to another strain and mapping detectable crossovers in 
the progeny of Prdm9EP/EP females. We chose WSB/EiJ as the out-
cross strain because it is highly divergent from the classical labora-
tory strains but still a member of the Mus musculus (M. m.) domesticus 
subspecies; it could therefore give us maximum resolution while 
avoiding fertility issues or unnecessary genetic complexity associated 
with intersubspecific crosses. We outcrossed B6.Prdm9+/EP mice to WSB/
EiJ (WSB) mice, producing male and female B6WSBF1 progeny het-
erozygous for Prdm9EP. We then intercrossed these F1 mice to 
produce B6WSBF2.Prdm9EP/EP mice, homozygous for the Prdm9EP 
mutation. All B6WSBF2.Prdm9EP/EP males were infertile with low 
testis weight (table S4). We backcrossed three B6WSBF2.Prdm9EP/EP 
females to wild-type B6 males and genotyped both the F2 females 
and 20 of their progeny with a genome-wide single-nucleotide poly-
morphism (SNP) array (18). This allowed us to map some of the 
crossovers that had occurred in the oocytes giving rise to these 
progeny. Only maternal crossovers were detectable in these proge-
ny, as their B6 fathers were homozygous at every locus. We limited 
our focus to the 94 informative crossovers that occurred in the 
Prdm9EP/EP mothers; crossovers that had occurred in the B6WSBF1 
generation were excluded. Of these, 26 occurred in intervals with 
no known PRDM9-dependent H3K4me3 peak (27.7%) (15). To 
exclude the possibility that these 26 putative PRDM9-independent 
crossovers occurred at heretofore unrecognized PRDM9 binding 
sites on the WSB chromosomes, we searched the B6 and WSB 
genomic sequences in the crossover regions for PRDM9Dom2 
binding motifs (19). Prdm9Dom2 is the endogenous Prdm9 allele in 
the B6 strain, of which Prdm9EP is a mutant version. Only hotspots 
defined by PRDM9Dom2 will therefore be bound in Prdm9EP/EP ho-
mozygotes. Of these 26 intervals, 17 (18.1% of total) had no apparent 
PRDM9Dom2 binding motifs in the WSB sequence when compared to 
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total crossovers, 12 (12.8%) could be classified as clearly PRDM9-de-
pendent based on very high-resolution crossover intervals contain-
ing a known hotspot (Fig. 2G). Notably, the B6WSBF2.Prdm9EP/EP 
females produced more offspring than B6.Prdm9EP/EP females (av-
erage offspring per female per month 4.55 versus 2.69, respectively; 
table S1), revealing an effect of genetic modifiers from the WSB ge-
netic background or hybrid vigor.
While the small scale and limited resolution of most of the in-
formative crossovers constrain any quantitative conclusions, this 
analysis does show directly that PRDM9-independent meiotic 
DSBs yield recombinant chromosomes in mice. These PRDM9- 
independent crossovers occurred in oocytes that gave rise to grossly 
normal and healthy animals, further supporting the idea that these 
PRDM9- independent recombination events support normal chro-
mosome segregation. In addition, the clearly PRDM9-dependent 
crossovers demonstrate that the residual methyltransferase activi-
ty of PRDM9EP is sufficient to promote PRDM9-dependent cross-
overs in oocytes, as it is for PRDM9-dependent meiotic DSBs in 
spermatocytes.
In summary, a severe catalytic hypomorph of Prdm9 allows for 
successful meiosis and fertility in female—but not male—M. m. 
domesticus mice. Meiotic progression is presumably facilitated by 
Fig. 2. Females homozygous for Prdm9EP are fertile. (A) Periodic acid–Schiff (PAS)–stained sections from 3-week postpartum ovaries in wild-type and Prdm9EP/EP mice 
in the B6 genetic background. Arrows show primary follicles. Scale bars, 100 m. (B) Oocytes per ovary in wild-type, heterozygous, and Prdm9EP/EP females (error bars, 
SEM). P values were not calculated as N = 2 is not sufficient for reaching statistical significance. (C) Litter sizes in wild-type, Prdm9−/−, and Prdm9EP/EP female mice (error 
bars, SEM). P values were calculated using the Mann-Whitney U test with Bonferroni correction for multiple testing. (D) Pups produced by Prdm9EP/EP female mice. 
(E) Coimmunolabeling detection of RNF212 foci (red, top row), MLH1 (red, bottom row), and SYCP3 (blue) in pachytene oocyte chromatin spreads in wild-type and mutant 
females. White arrows highlight unsynapsed regions of chromosomes. Scale bars, 10 m. (F) Violin plot with dots showing numbers of MLH1 foci per meiotic oocyte (error 
bars, SEM), in wild-type, Prdm9−/−, and Prdm9EP/EP mice. P values were calculated using the Mann-Whitney U test with Bonferroni correction for multiple testing. (G) Dia-
gram showing proportions of PRDM9-dependent and PRDM9-independent crossovers in progeny of B6WSBF2.Prdm9EP/EP females (n = 94). Photo credit: Natalie R. Powers 
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the activation of a normally quiescent PRDM9-independent recom-
bination pathway in response to limited PRDM9 activity.
Genetic background– and sex-limited requirement 
for PRDM9 in mice
The human case of a fertile PRDM9-null female (12), and the higher 
fertility in the B6WSBF2.Prdm9EP/EP females, led us to examine the 
impact of different genetic backgrounds on meiotic recombination 
and fertility in the absence of Prdm9. To this end, we introgressed 
the B6.Prdm9-null allele onto the CAST/EiJ and C3H/HeJ inbred 
backgrounds for five generations (~5% residual heterozygosity, 
henceforth CAST.Prdm9−/− and C3H.Prdm9−/−, respectively). These 
strains derive from distinct house mouse subspecies (M. m. castaneus 
and M. m. domesticus, respectively) that diverged ~0.5 million years 
ago (20, 21). We chose these strains for the contrast they provide: 
C3H/HeJ is a classical laboratory strain and closely related to B6, 
whereas CAST/EiJ is a wild-derived inbred strain of M. m. castaneus, 
a divergent subspecies. There is no Prdm9-dependent hybrid steril-
ity in B6CASTF1 hybrids, which might influence interpretation of 
the phenotype (22). Notably, CAST.Prdm9−/− females have func-
tional oocytes and are fertile, producing grossly healthy, fertile off-
spring, while C3H.Prdm9−/− females, like B6.Prdm9−/− females, are 
infertile (Fig. 3, A to C, and table S2). To determine the recombi-
nation status in P0 CAST.Prdm9−/− oocytes, we immunostained 
CAST.Prdm9−/− ovarian meiotic spreads with antibodies against 
MLH1 and SYCP3 (Fig. 3D and table S3). We observed normal syn-
apsis and MLH1 frequency in ~96% of CAST.Prdm9−/− pachytene 
oocytes, although there was a significant reduction in the average 
number of MLH1 foci in these oocytes compared to the CAST. 
Prdm9+/+ control oocytes (P = 0.02149, Mann-Whitney U test; 
Fig. 3, D and E, and table S3). This might be due to alteration of DSB 
sites or recombination rate in the absence of PRDM9 in the CAST 
genetic background. B6CASTF1.Prdm9−/− and C3HCASTF1. 
Prdm9−/− females were fertile, while B6C3HF1.Prdm9−/− females 
were infertile (Fig. 3C and table S2), indicating the presence of one 
or more dominant modifiers in the CAST genetic background that 
abrogate the requirement for PRDM9 in oocytes for fertility. All 
Prdm9-deficient males of the genetic backgrounds we tested— 
CAST.Prdm9−/−, B6.Prdm9−/−, and C3H.Prdm9−/−—exhibited mei-
otic arrest (fig. S2A) and failed to produce live-born offspring. 
Although these males are infertile, we did observe round sperma-
tids and elongating spermatids in histological sections of some 
CAST.Prdm9−/− testes (fig. S2, A to C). This suggests a rescue of 
meiotic arrest in some spermatocytes, as previously observed in 
PWD.Prdm9−/− males (11). In conclusion, the requirement for 
PRDM9 in recombination initiation and fertility in mice is sexually 
dimorphic and is modulated by background-specific genetic modi-
fiers that lead to fertility despite PRDM9 deficiency.
To identify the CAST modifier(s) that allow for Prdm9-null fe-
male fertility, we generated 75 B6CASTF2.Prdm9−/− female mice to 
perform quantitative trait locus (QTL) mapping, with the total 
number of ovarian follicles per female as the phenotype [see Fig. 3 
(F and H) and Materials and Methods for details]. We chose this 
phenotype because the number of oocytes in mature ovaries cor-
relates with the efficacy of meiotic DSB repair and oocyte survival 
(23). The analysis yielded a significant QTL on chromosome 5, with a 
peak at ~100.4 Mb [1.5 LOD (logarithm of the odds) score drop: 
72.9 to 127.65 Mb, permutation- derived significance threshold cal-
culated at  = 0.05] (Fig. 3, G and H, and fig. S2D). Intriguingly, 
this QTL contains two critical meiotic genes: ring finger protein 
212 (Rnf212 at 108.7 Mb) and checkpoint kinase 2 (Chk2 at 110.8 Mb). 
The success of the meiotic recombination process depends on 
the efficient repair of meiotic DSBs and crossover formation, while 
oocyte survival depends on successful passage through a checkpoint 
that monitors DNA damage. The roles of RNF212 and CHK2 in 
DNA damage surveillance in oocytes nominate them as compel-
ling candidate genetic modifiers of PRMD9 (23, 24). RNF212 is a 
SUMO (Small Ubiquitin-like Modifier) ligase essential for cross-
over formation and oocyte quality control (24). It has been reported 
that localization of RNF212 to DSB sites acts as a “memory” of 
unrepaired DSBs, thus promoting apoptosis of defective oocytes 
during the diplotene to dictyate meiotic substage transition (24). 
Loss of Rnf212 leads to persistent DSBs and synapsis defects, and 
Rnf212 knockout females are infertile (24). The other candidate gene, 
Chk2, encodes a meiotic checkpoint kinase responsible for DNA 
damage surveillance in oocytes (23). Ablation of CHK2 prevents 
oocyte elimination in response to both radiation-induced DNA 
damage and persistent meiotic DSBs due to genetic mutation of 
Trip13 (23). Both the Rnf212 and Chk2 genomic sequences are well 
conserved between B6 and CAST mice (~99% sequence identity; 
fig. S3, A and B); however, regulatory variants outside the genes 
themselves may play a critical role. To further elucidate the mecha-
nism behind this QTL, we examined Rnf212 and Chk2 experimen-
tally for their potential roles as genetic modifiers of Prdm9.
Modulation of a meiotic DNA damage checkpoint leads 
to female-limited fertility in Prdm9-null B6 mice
The first candidate modifier gene we considered was Rnf212. In 
meiotic spreads, RNF212 protein expression and colocalization pat-
terns were similar between CAST.Prdm9−/− meiotic oocytes and 
CAST.Prdm9+/+ oocytes (fig. S4). As mentioned above, crossover 
formation in CAST.Prdm9−/− meiotic oocytes is normal (Fig. 3, 
D and E), suggesting that the role of RNF212 in crossover formation 
in CAST.Prdm9−/− remains intact. While the oocyte count of 
B6.Rnf212−/− females is normal, these mice are infertile due to the 
absence of crossovers (24). RNF212 deficiency promotes survival of 
oocytes with genetic and radiation-induced DNA damage, sug-
gesting an additional role for RNF212 as a proapoptotic cell cycle 
regulator that promotes elimination of defective oocytes (24). In 
CAST.Prdm9−/− females, delayed activation of RNF212 in this ca-
pacity could conceivably promote the survival of oocytes with un-
repaired DSBs while still fulfilling its role in crossover formation. 
Further investigation is needed to understand the exact role of 
RNF212 in PRDM9-dependent and PRDM9-independent meiotic 
recombination in CAST oocytes. However, because RNF212 ex-
pression and RNF212 colocalization with the SC protein SYCP3 
(fig.S4) are similar in Prdm9+/+ and Prdm9−/− CAST oocytes, we did 
not pursue it further, considering that additional validation would 
require in-depth sequencing, genetic models, and analysis of func-
tional domains beyond the scope of the present study.
We next turned our attention to Chk2, which encodes a proapop-
totic DNA damage surveillance kinase whose ablation is known to 
allow survival of oocytes with persistent DNA damage (23). We 
speculated that ablation of Chk2 might also allow for the survival of 
Prdm9-deficient oocytes. To determine directly whether Prdm9-
null oocytes complete meiosis in the face of Chk2 deficiency, we 
generated Prdm9−/−Chk2−/− double knockout females in the B6 ge-
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oocytes from B6.Prdm9−/− single mutants, most exhibited wide-
spread asynapsis and persistent unrepaired DSBs, revealed by per-
vasive BRCA1 (breast cancer 1 protein), H2AFX (phosphorylated 
form of H2A histone family member X), and IHO1 (interactor of 
HORMAD1 1)  signals (figs. S5, A to D, and S6A). Only ~4% of these 
P0 oocytes had fully synapsed chromosomes stained with RNF212, 
MLH1, and MLH3 foci (markers of mature crossovers) (Fig. 4, A to D, 
fig. S5D, and table S3). This phenotype was substantially improved 
in B6.Prdm9−/−Chk2−/− double-mutant oocytes, with a significant 
increase in the number of oocytes with fully synapsed chromosomes 
Fig. 3. CAST/EiJ Prdm9-null females are fertile. (A) Immunofluorescence staining of histology sections from 3-week postpartum ovaries in wild-type and Prdm9−/− 
females of different genetic backgrounds. DDX4 (red, also known as MVH) marks oocytes. DNA is stained with 4′,6-diamidino-2-phenylindole (DAPI) (blue). Arrowheads 
indicate primordial follicles. Scale bars, 100 m. Note the oocyte depletion in Prdm9−/− mice in the B6 and C3H genetic backgrounds, in contrast to survival of oocytes in 
wild-type and Prdm9−/− mice in the CAST genetic background. (B) Pups produced by CAST.Prdm9−/− female mice. (C) Reproductive productivity of wild-type and Prdm9−/− 
females in different genetic backgrounds. P values were calculated using the Mann-Whitney U test with Bonferroni correction for multiple testing. NS, not significant. 
(D) Coimmunolabeling detection of MLH1 foci (red) in pachytene oocyte chromatin spreads, also labeled with antibody against SYCP3 (blue) in wild-type and Prdm9−/− 
CAST females. Scale bars, 10 m. (E) Violin plot with dots showing numbers of MLH1 foci per oocyte (error bars, SEM). The genotypes of mice tested are indicated below 
the graphs. P values were calculated using the Mann-Whitney U test with Bonferroni correction for multiple testing. (F) Scheme of construction of B6CASTF2.Prdm9−/− 
female cohorts used for SNP array genotyping [Giga Mouse Universal Genotyping Array (GigaMUGA)]. Seventy-five F2 females were generated by crossing 
B6CASTF1.Prdm9−/− and B6CASTF1.Prdm9+/− females with B6CASTF1.Prdm9+/− males. Eight-week-old B6CASTF2.Prdm9−/− females were phenotyped for oocyte quantity 
and genotyped. (G) Quantitative trait locus (QTL) mapping, with the total number of ovarian follicles (refer to Materials and Methods for details) per B6CASTF2.Prdm9−/− 
female as the phenotype. QTL (pink) reached significance on chromosome 5, with a peak at ~100.4 Mb (1.5 LOD drop: 72.9 to 127.65 Mb, mm10). (H) Genotype effects of 
the chromosome 5 QTL. CAST alleles affect oocyte number positively, as highlighted by CC (violet) and BC (orange) lines, relative to B6 homozygotes (BB, green). 
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devoid of BRCA1, H2AFX, and IHO1 (~26%; figs. S5, E to H, and 
S6A). We also observed an approximate threefold increase in the 
number of dictyate oocytes in P0 B6. Prdm9−/−Chk2−/− double- 
mutant females, compared to B6.Prdm9−/− females (figs. S5, E to H, 
and S6B). Only a small number of growing follicles survived in 
B6.Prdm9−/− females (Fig. 5, A and C). We isolated metaphase I 
(MI) oocytes from young B6.Prdm9−/− and B6.Prdm9−/−Chk2−/− 
females and noted a significant increase (~25%) in the number 
of metaphase oocytes with normal chiasmata between the homol-
ogous chromosomes in B6.Prdm9−/−Chk2−/− females relative to 
B6.Prdm9−/− females (Fig. 4, E and F). We conclude that CHK2 
eliminated oocytes that failed to repair meiotic DSBs, but oocytes 
in which recombination was completed were not eliminated and 
progressed through folliculogenesis. Although ~4% of B6.Prdm9−/− 
oocytes at P0 had a full complement of crossovers, this is probably 
not sufficient for fertility, especially given further oocyte elimina-
tion after P0 during follicle formation and atresia. We propose that 
with the removal of Chk2, more Prdm9−/− oocytes escape the mei-
otic DNA damage checkpoint and subsequently complete DSB 
repair, resulting in a higher oocyte reserve.
To test the impact of improved meiotic phenotypes on oocyte 
number and fertility, we estimated the oocyte number in B6.Prdm9−/− 
Chk2−/− females and performed fertility tests with wild-type B6 
males. In contrast to B6.Prdm9−/− females, B6.Prdm9−/−Chk2−/− fe-
males produced at least one litter of grossly healthy, fertile offspring 
over a 6-month period (Fig. 5, B to D, fig. S6D, and table S2), indi-
cating some functional ovarian reserve. However, there was a high 
incidence of pregnancy losses and perinatal deaths (fig. S6E), sug-
gesting that oocyte quality is compromised, consistent with the ob-
servations of metaphase oocytes in B6.Prdm9−/−Chk2−/− females. 
The extent of this fertility was much lower than that observed in 
CAST.Prdm9−/− females, suggesting CAST modifiers in addition 
to Chk2. In contrast to females, Chk2 deficiency did not rescue fer-
tility in B6.Prdm9−/− males; both single- and double-mutant males 
were infertile with complete meiotic arrest (fig. S6C). Together, 
these results demonstrate that, in females, a Prdm9-independent 
recombination pathway can give rise to the required number of 
crossovers for production of healthy offspring, probably facilitated 
by modulation of the Chk2-dependent DNA damage surveillance 
mechanism.
Fig. 4. Chk2 ablation rescues meiosis in Prdm9-null females in the B6 genetic background. (A and C) Coimmunolabeling detection of MLH3 foci (red, A), MLH1 (red, C), 
and SYCP3 (blue, both A and C) in pachytene oocyte chromatin spreads from wild-type and mutant females. Yellow arrowheads highlight unsynapsed regions of chro-
mosomes. Scale bars, 10 m. (B and D) Violin plots with dots showing numbers of MLH3 (B) and MLH1 (D) foci per meiotic oocyte (error bars, SEM). The genotypes of mice 
tested are indicated below the graphs. P values were calculated using the Mann-Whitney U test with Bonferroni correction for multiple testing. (E and F) Chromosome 
configuration in meiosis MI analyzed by chromosome spreads from different mutant and control oocytes, pictured in (E) and quantified in (F). In (E), DNA (blue) and kine-
tochores (red) were detected by DAPI and CREST antiserum, respectively. Scale bars,10 m. Multiple univalents in a B6.Prdm9−/− oocyte are indicated with white arrow-
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DISCUSSION
In this study, we find that female meiosis tolerates critically low lev-
els of catalytically active PRDM9, or even no PRDM9 at all in some 
genetic backgrounds, because a PRDM9-independent recombina-
tion pathway compensates successfully. The meiotic DNA damage 
repair protein CHK2 acts as a modifier; removing it allows comple-
tion of meiosis and fertility in females lacking active PRDM9. This 
is not the case for males; Prdm9EP/EP and Prdm9-null males in the 
genetic backgrounds examined were infertile. Overall, these results 
demonstrate that the requirement for functional PRDM9 during 
meiosis varies substantially by genetic background and by sex and 
that there are alternative pathways for effective recombination.
As shown by our genetic analyses, elimination of CHK2-dependent 
DNA damage checkpoint activation can restore female fertility in 
the absence of PRDM9. CHK2 triggers elimination of oocytes with 
persistent DNA damage. It is possible that PRDM9-independent 
DSBs occur later or that their repair is inefficient or prolonged, thus 
causing DSBs to persist past the timely activation of the CHK2- 
dependent DNA damage checkpoint, leading to oocyte elimination. 
Ablation of Chk2 and consequent elimination of checkpoint sur-
veillance may promote survival of oocytes by allowing extra time 
for PRDM9-independent crossovers to accumulate, permitting 
completion of meiosis in a sufficient number of oocytes to produce 
offspring. However, this is not a fully adequate explanation of the 
modifier effect because, although B6.Prdm9−/−Chk2−/− females were 
fertile, they were not as productive as CAST.Prdm9−/− females. 
Thus, while CHK2 is clearly mechanistically involved, at least in B6 
females, it alone does not explain the disparity between B6 and 
CAST female fertility in the absence of PRDM9. Furthermore, the 
predicted causative CAST variant(s) in Chk2 seem to be dominant 
and possibly neomorphic, unlike the recessive null mutation that 
restores fertility in B6.Prdm9−/−Chk2−/− females.
A recent study showing partial restoration of meiosis in PWD. 
Prdm9−/− males, but not females, speculated that mice with higher 
crossover rates can alleviate the synapsis defects characteristic of 
Prdm9-null meiocytes by increasing the probability of synapsis- 
promoting DSBs (11). PWD males have higher recombination rates 
than females—unlike most other mouse strains, including B6 and 
CAST, in which females have higher recombination rates than 
males (25, 26). The dosage effect of the crossover maturation 
factor RNF212 on crossover rate (27) suggests that alteration in the 
level or timing of Rnf212 expression could markedly alter crossover 
rate. Thus, higher crossover rates in CAST females (or PWD males) 
in comparison to CAST males (or PWD females) may be modulated by 
allele-specific genetic regulation or functional variation in RNF212 
dosage during pachynema in different genetic backgrounds and sexes. 
Alternatively, if RNF212 does indeed participate in DNA damage 
surveillance as a memory of persistent DSBs (24), some allelic variants 
may be more permissive than others. It is therefore possible that both 
Chk2 and Rnf212 are modifiers of the PRDM9- independent fertility 
phenotype or that additional CAST genome variants affect timing 
or efficacy of DNA repair, the checkpoint, or other features of meiosis 
that determine whether or not oocytes activate the checkpoint.
Another possible explanation of fertility restoration in CAST fe-
males lacking PRDM9 is that repair of PRDM9-independent DSBs 
is more efficient in the CAST genetic background than in the B6, 
with fewer oocytes exhibiting enough persistent to activate the 
DNA damage checkpoint. Ability to repair DSBs may be a limiting 
factor in B6 mice; the high pre- and perinatal death rate (fig. S6E) 
and the aneuploidy rate we observed in developing oocytes (Fig. 4, 
E and F) indicate that, in B6 mice, the PRDM9-independent path-
way leads to maturation of defective oocytes. Although similar 
modification of an infertility phenotype via removal of Chk2 was 
reported for Trip13-deficient females (23), there are critical differ-
ences between causes of infertility in Trip13- and Prdm9-deficient 
females. In Trip13 mutants, crossovers originate from PRDM9- 
dependent DSBs, and complete synapsis is achieved (23, 28); in 
contrast, Prdm9-deficient oocytes exhibit widespread chromosomal 
asynapsis and form crossovers at ectopic DSBs. Trip13-deficient 
oocytes are eliminated due to inefficient repair of DSBs in a non-
crossover pathway (23). Removal of Chk2 in Trip13 mutants rees-
tablishes ovarian reserve and fertility by allowing oocyte survival and 
additional time for DSB repair (23); however in Prdm9-deficient 
oocytes, Chk2 removal must also allow chromosomal synapsis and 
Fig. 5. Chk2 ablation rescues fertility in Prdm9-null females in the B6 genetic background. (A) PAS-stained histological sections of 3-week postpartum ovaries from 
wild-type, single-, and double-mutant females in the B6 genetic background. Scale bars, 200 m. (B) Pups produced by B6.Prdm9−/−Chk2−/− female mice. (C) Oocyte 
quantification in mutant and wild-type animals. (D) Litter sizes in mutant and control females. P values were calculated using the Mann-Whitney U test with Bonferroni 
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recombination at non-PRDM9 DSBs. To our knowledge, this is the 
first evidence that modulation of a DNA damage checkpoint pro-
tein can allow survival of oocytes that undergo genetic recombina-
tion via a PRDM9-independent pathway.
While checkpoint modulation appears to be a feature allowing 
oocyte, but not spermatocyte, survival in the absence of PRDM9, at 
least in certain genetic backgrounds, the question of the genetic and 
cellular mechanisms behind this dimorphism is undoubtedly more 
complex. Although recombination is essentially the same process in 
both sexes, spermatogenesis and oogenesis are fundamentally dif-
ferent cell differentiation programs. Two key differences unique to 
males that might explain the sexually dimorphic requirement for 
PRDM9 are meiotic sex chromosome inactivation (MSCI), which is 
the silencing of most genes on the sex chromosomes from pachynema 
of meiotic prophase I into spermiogenesis (29), and deployment of 
Piwi-interacting RNAs (piRNAs) (30, 31). MSCI is triggered by XY 
asynapsis in spermatocytes and is marked by sequestration of the sex 
chromosomes in the “sex body” (29). Spermatocytes undergoing 
PRDM9-deficient meiotic arrest in B6 mice do not form a normal 
sex body, as unsynapsed autosomes and unrepaired DSBs compro-
mise recruitment of silencing factors to sex chromosomes (8, 17, 32). 
This could potentially lead to failure of MSCI, triggering meiotic 
arrest of PRDM9-deficient spermatocytes (8, 32). Inappropriate 
critical gene silencing on the asynapsed autosomes due to meiotic 
silencing of unsynapsed chromatin (MSUC) may also contribute to 
spermatocyte elimination (29). Oocytes, which are not affected by 
MSUC, may escape these outcomes (29). In mammals, piRNAs are 
necessary to suppress expression of L1 retrotransposons during 
spermatogenesis (30, 31). Mutation or deficiency of the piRNA path-
way contributes to male-limited sterility (33–35), and it was recently 
reported that the expression of piRNAs is misregulated in Prdm9-
null spermatocytes (36). Thus, it is possible that dysregulation of the 
piRNA pathway contributes to the postmeiotic problems in Prdm9-
null germ cells that undergo partial meiotic arrest, as seen in PWD 
(11), CAST, and other genetic backgrounds (this report).
In addition to invoking intriguing meiotic mechanisms, the sex-
ually dimorphic responses to PRDM9 deficiency described here have 
significant evolutionary implications. Prdm9 is the first and only 
known mammalian speciation gene (37). Prdm9 interacts with an 
unknown element on the X chromosome to cause male-limited 
meiotic arrest and hybrid sterility in F1 hybrids between the females 
of the M. m. musculus strain PWD/PhJ and the males of certain 
M. m. domesticus strains, including B6 (37, 38). Sterile (PWDXB6)
F1 hybrid males exhibit a significant enrichment of DSBs at PRDM9- 
independent hotspots and high rates of autosomal asynapsis that 
trigger pachytene checkpoint activation (38, 39). Chromosome 
asynapsis is also observed in F1 hybrid females, although the pheno-
type is markedly less severe than in F1 hybrid males, and females 
remain fertile (38, 40). Our findings suggest that F1 hybrid females 
may retain fertility by using a PRDM9-independent DSB repair 
mechanism to evade checkpoint activation. Our work further nom-
inates Chk2 as a key modifier of these sex and strain differences in 
the meiotic tolerance for PRDM9-independent DSB repair.
The pattern of male-limited hybrid sterility in the (PWDxB6)F1 
model follows Haldane’s rule, which postulates that when only one 
sex of an interspecies hybrid experiences sterility or inviablity, it is 
the heterogametic sex (41) . Many hypotheses, largely based on the role 
of sex chromosomes, have attempted to explain Haldane’s rule, in-
cluding the faster-male theory, the faster X theory, meiotic drive, 
and the dominance theory (41). However, the mechanistic basis for 
sexually dimorphic hybrid sterility remains unclear in most docu-
mented cases. The sexually dimorphic requirement for PRDM9 for 
fertility and the relaxed stringency of DNA damage surveillance in 
females that we report here provide a possible explanation for 
Haldane’s rule in the (PWDXB6)F1 hybrid sterility model. Notably, 
hybrid sterility in this system depends on a genetic interaction be-
tween Prdm9 and an X-linked locus affecting DNA DSB repair be-
tween homologous chromosomes during meiotic prophase (38, 40). 
The sex-specific manifestation of (PWDXB6)F1 hybrid sterility may 
also be driven, at least in part, by sex and genetic differences at an 
autosomal gene, Chk2.
Finally, Prdm9 is a fundamental evolutionary innovation that 
is thought to have evolved to direct recombination away from func-
tional elements, safeguarding these regions from recombination- 
associated mutagenesis (7). As in most cases of evolutionary innovation, 
however, there are trade-offs. Use of a DNA binding protein to specify 
regions of recombination requires that sufficient numbers of the 
cognate binding sites of that protein remain intact. However, PRDM9- 
dependent hotspots extinguish themselves via gene conversion, 
leading to gradual erosion of the hotspot-binding motifs recognized 
by a particular PRDM9 variant and, ultimately, meiotic failure and 
infertility (42, 43). One mechanism through which populations may 
avoid this fate is the emergence of new Prdm9 alleles that recognize 
new suites of hotspots (42, 43).
Prdm9 is highly polymorphic and its DNA binding domain is 
rapidly evolving via positive selection. Our findings introduce an 
additional, novel complexity to the dynamic interplay between 
hotspot erosion and reproductive fitness, i.e., sex differences in the 
usage or effectiveness of PRDM9-independent pathways may render 
one sex more resilient to the loss of PRDM9 activity, leading to potential 
sex-specific fitness effects of hotspot erosion. Further work is required 
to elucidate the mechanistic details of the sexually dimorphic re-
sponses to lack of PRDM9; nevertheless, the theoretical implications 
raised by this phenomenon present fascinating new insights into 
the checks and balances that constrain one of the most fundamental 
evolutionary processes in mammals—genetic recombination.
MATERIALS AND METHODS
Ethics statement
The animal care rules used by The Jackson Laboratory are compatible 
with the regulations and standards of the U.S. Department of Agri-
culture and the National Institutes of Health. The protocols used in 
this study were approved by the Animal Care and Use Committee of 
The Jackson Laboratory (summary nos. 04008 and 15001). Euthanasia 
was carried out by cervical dislocation.
Mouse strains
Mice used in this study were acquired from The Jackson Laboratory. 
The following strains were used: C57BL/6J (stock number 000664), 
WSB/EiJ (stock number 001145), CAST/EiJ (stock number 000928), 
C3H/HeJ (stock number 000659), B6;129P2-Prdm9tm1Ymat/J (stock 
number 010719), C57BL/6J-Prdm9<em2Kpgn>/Kpgn (stock number 
28854; Prdm9EP). C57BL/6 N-Atm1Brd Chek2tm1b(EUCOMM)Hmgu/JMmucd 
(stock number 047090-UCD, also known as Chk2) mice were ac-
quired from the Knockout Mouse Project repository at The Jackson 
Laboratory. The B6;129P2-Prdm9tm1Ymat/J mice were backcrossed to 
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and CAST/EiJ-Prdm9−/− congenic mice were generated by back-
crossing with B6;129P2-Prdm9tm1Ymat/J mice for five generations. 
C57BL/6J-Prdm9<em2Kpgn>/Kpgn mice were generated by introducing 
a point mutation (glu365pro) via CRISPR-Cas9 gene editing, onto the 
C57BL/6J genetic background (fig. S1A). Gene editing was performed 
by the Genetic Engineering Technology core at The Jackson Laboratory.
Fertility tests
Control and experimental females (2 to 6 months old) were housed 
with fertile males for a period of up to 6 months. A female was con-
sidered fertile if she gave live birth at least once. Litter size was de-
termined by counting pups on the day of birth. Embryo loss during 
pregnancy was assessed by comparing the number of live births per 
pregnancy. Briefly, females were mated to wild-type males and the 
presence of a copulation plug was checked the next morning and 
recorded. At 19.5 dpc (days post coitum), pregnant females were 
expected to deliver. Embryo loss during pregnancy was clear due to 
sinking of stomach in pregnant females due to reabsorption of 
embryos by 16.5 dpc.
Tissue fixation, histology, immunofluorescence, and  
follicle quantification
Whole testes and ovaries were fixed for 24 hours in Bouin’s fixative 
at room temperature and then washed three times with 70% ethanol 
at room temperature for 1 hour per wash. Testis cross sections were 
stained with periodic acid–Schiff (PAS) diastase by standard methods 
and imaged at ×40 magnification with a NanoZoomer 2.0-HT. 
Ovaries from 3- and 8-week-old females were fixed and embedded 
in paraffin, serially sectioned at 5 m, and stained by hematoxylin 
and eosin or PAS. Follicle quantification was performed as published 
previously (23). Briefly, every fifth section was examined for the 
presence of the following classes of oocytes/follicles: primordial, 
primary, secondary, and mature. For QTL analysis, total follicle 
number was used. Statistical differences in follicle number between 
different genotypes were evaluated using the nonparametric two-
tailed Mann-Whitney U test with Bonferroni correction using R.
For immunofluorescence, testes from 2-month-old and ovaries 
from 3-week-old mice were fixed in 4% paraformaldehyde and sec-
tioned at a thickness of 5 m, matured overnight, dewaxed, rehydrated, 
and heated in 10 mM sodium citrate buffer (pH 6.0) for antigen 
retrieval. Slides with testis sections were incubated with antibody 
dilution buffer [1.5% bovine serum albumin (BSA), 5% donkey serum, 
0.05% Triton X-100 in phosphate-buffered saline (PBS), and 0.2× 
cocktail of protease inhibitors] for 1 hour at room temperature. 
Slides were incubated overnight with diluted anti-PRDM9 (1:100) 
(32), anti- H2AFX (1:5000; Upstate #07-164), and anti-SYCP3 (1:100; 
D-1; Santa Cruz #74569) in ADB buffer. Slides with ovary sections 
were stained using rabbit anti-MVH (mouse Vasa homolog) (1:500; 
Abcam #27591). Immunofluorescent staining was performed by 
staining the sections for 2 hours at 37°C, using diluted appropriate 
secondary antibodies conjugated with Alexa Fluor 488/fluorescein 
isothiocyanate, Alexa Fluor 594/CY3, and Alexa Fluor 647/CY5 
(1:300; Molecular Probes/Invitrogen or Jackson Immunoresearch 
Laboratories). Stained sections were mounted using ProLong Gold 
Antifade Mountant with 4′,6-diamidino-2-phenylindole (DAPI) 
(P36935; Molecular Probes/Invitrogen) at 4°C overnight and imaged 
after 24 hours using a Leica SP5 confocal microscope and/or Zeiss 
AxioImager.Z2 epifluorescence microscope. Images were processed 
and adjusted using Adobe Photoshop (Adobe Systems).
Immunostaining of spread meiocytes
The meiocyte spreads were prepared by using the hypotonic protocol 
as described previously (38). The nuclei were immunostained using 
the following primary antibodies: rat polyclonal anti-SYCP3 (44), 
mouse monoclonal anti-MLH1 (Abcam #14206), mouse monoclonal 
anti-H2AFX (Upstate, #05-636), mouse monoclonal anti-SYCP3(D-1) 
(Santa Cruz #74569), guinea pig polyclonal anti-IHO1 (45), rabbit 
polyclonal anti-RNF212 (27), rabbit antibody anti-MLH3 (46), and 
rabbit polyclonal anti-BRCA1(C-20) (Santa Cruz #642); and the 
following secondary antibodies: goat anti-rabbit immunoglobulin 
G (IgG)–Alexa Fluor 488 (Molecular Probes, A-11034), goat anti- 
mouse IgG-Alexa Fluor 568 (Molecular Probes, A-11031), goat 
anti-rabbit IgG-Alexa Fluor 568 (Molecular Probes, A-11036), goat 
anti-mouse IgG-Alexa Fluor 350 (Molecular Probes, A-21049), 
goat anti-mouse IgG-Alexa Fluor 647 (Molecular Probes, A-21236), goat 
anti-rabbit IgG-Alexa Fluor 647 (Molecular Probes, A-21245), and 
goat anti–guinea pig IgG-Cy3 (Chemicon, #AP108C). Stained 
meiocytes were mounted using ProLong Gold Antifade Mountant 
with DAPI (P36935; Molecular Probes/Invitrogen) at 4°C overnight 
and imaged after 24 hours using a Zeiss AxioImager.Z2 epifluores-
cence microscope. Images were processed and adjusted using Adobe 
Photoshop (Adobe Systems). MLH1 foci were counted using ImageJ 
software (http://rsbweb.nih.gov/ij/). Statistical differences in MLH1 
and MLH3 focus number per meiocyte between different genotypes 
were evaluated using the nonparametric two-tailed Mann-Whitney 
U test with Bonferroni correction using R. Meiocytes with partially 
asynapsed or desynapsed chromosomes were also considered as a 
data point for the MLH1 and MLH3 analysis.
GigaMUGA genotyping and QTL analysis
Giga Mouse Universal Genotyping Array (GigaMUGA) genotyping 
was carried out by Neogen’s commercial service (18). Invariant SNPs, 
SNPs with erroneous or missing calls in parental and F1 control 
samples, SNPs with >10% missing data across all samples, and sites 
that deviated from Hardy-Weinberg expectations were excluded. 
Putative genotyping errors were identified as tight double recombi-
nants and recoded as missing data. A total of 54,629 genotypes sur-
vived these filters. Cleaned genotypes were then down-sampled to 
every 10th marker to eliminate a large number of uninformative 
markers, reduce the impact of genotyping error on map inflation, 
and expedite the process of map construction. This thinned geno-
type dataset was then used to construct an empirical genetic linkage 
map with the est_map call in R/qtl2 (47). Recombination fractions 
were converted to map distances using the Carter-Falconer mapping 
function (48) and assuming a 1% residual genotyping error rate.
Single QTL mapping of recombinant B6CASTF2.Prdm9−/− females 
was performed using the linear mixed model framework implemented 
in the R/qtl2 package. Conditional genotype probabilities were cal-
culated from the downsized marker dataset without the inclusion of 
any pseudomarkers. The nonrandom genetic structure among sam-
ples was specified via a kinship matrix computed using the leave-
one-chromosome-out method. QTL significance thresholds were 
determined by 1000 permutations of the data. To improve fit to nor-
mality, follicle counts were natural log transformed before mapping.
MI spreads
MI spreads and staining were performed as previously described (49). 
Briefly, pregnant mare’s serum gonadotropin (5 IU) was injected to 
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Cumulus-oocyte complex or single germinal vesicle oocytes were 
collected in minimal essential medium (MEM)/polyvinylpyrrolidone 
(PVP) medium [25 mM Hepes, PVP (3 mg/ml), 2.5 M milri-
none]. After removing cumulus cells, denuded oocytes were ma-
tured for MI by incubating in a single drop of CZB (Chatot Ziomek 
Bavister)/glutamine [81.62 mM NaCl, 4.83 mM KCl, 1.18 mM KH-
2PO4, 1.18 mM MgSO4 7H2O, 25.12 mM NaHCO3, 1.7 mM CaCl 
2H2O, 31.3 mM sodium lactate, 0.27 mM sodium pyruvate, 0.11 mM 
EDTA, BSA (3 mg/ml), 7 mM taurine, gentamicin (10 g/ml), phenol 
red (10 g/ml), and 1 mM glutamine]. Zona pellucida was removed 
from matured MI oocytes by using EmbryoMax Acidic Tyrodes 
solution (Millipore), and then oocytes were placed in spread solu-
tion (H2O, 0.16% Triton X-100, 6 mM dithiothreitol, 0.64% PFA). 
After slides were completely dried, slides were incubated with block-
ing solution (3% BSA in PBS) for 10 min, at room temperature. 
Immunostaining was performed by incubating slides in anti- CREST 
antibody (Anti-Centromere Antibodies derived from human CREST 
patient serum) (Antibodies Inc., 15-234-0001) diluted in blocking 
buffer for 3 hours. After washing with blocking buffer, secondary 
antibody (anti-human Alexa Fluor 647) incubation was performed 
for 1.5 hours. Slides were mounted in Vectashield with DAPI.
H3K4me3 ChIP-seq
ChIP-seq for H3K4me3 was performed with spermatocytes isolated 
from 14 dpp (days postpartum) Prdm9EP/EP animals, as previously 
reported (15), using a commercially available polyclonal -H3K4me3 
antibody (EMD Millipore Cat# 07-473). DNA samples were sequenced 
on the Illumina NextSeq 500 platform, with 75-bp reads and trimmed 
for quality using trimmomatic. Sequence data were aligned to the 
mouse mm10 genome using BWA (Burrows-Wheeler aligner) v0.7.9a, 
and duplicate reads and reads which failed to align to unique posi-
tions in the genome were discarded. This resulted in a total of 
26,209,084 and 28,910,782 aligned reads, respectively, for each of 
two biological replicates. The raw Fastq files were merged and aligned 
to mm10 by the same procedure for analysis, yielding a total of 
45,931,625 aligned reads in the merged sample. Sequence data are 
available at National Center for Biotechnology Information (NCBI) 
Gene Expression Omnibus (GEO; www.ncbi.nlm.nih.gov/geo) under 
accession number GSE144144.
For the wild-type B6 sample, the sequence data used were previously 
reported by Baker et al. (15). Data are available under GEO acces-
sion number GSE52628 (sample accession numbers GSM1273023 
and GSM1273024). These data were merged and mapped to mm10 
using the above procedure, resulting in 39,973,027 total aligned reads.
H3K4me3 peak calling
H3K4me3 peaks were called using MACS v1.4, default parameters, 
with a P value cutoff of 0.01, using treatment and control samples. 
For a control sample, the merged file with the two input B6 biological 
replicates from Baker et al. (15), mapped to mm10 and described 
above, was used. To determine overlap between known PRDM9- 
dependent H3K4me3 peaks and ChIP-seq peak sets, we used 
BedTools (v2.27.0) intersect with default parameters, except for a 
requirement for 20% overlap (f = 0.20).
We classified H3K4me3 peaks in spermatocytes as PRDM9- 
dependent based on a previously published H3K4me3 ChIP-seq ex-
periment from our lab. This experiment compared H3K4me3 peaks 
in spermatocytes isolated from wild-type B6 males to those from 
B6.Prdm9Cst knock-in males, in which the DNA binding domain of 
the highly divergent Prdm9Cst allele replaces that of the endogenous 
Prdm9Dom2 allele in an otherwise B6 genetic background. PRDM9- 
dependent H3K4me3 sites are defined as those present in B6 spermato-
cytes but absent in B6.Prdm9Cst spermatocytes. These PRDM9-dependent 
H3K4me3 peak locations for B6 were previously described by Baker 
et al. (15); files with these hotspot locations are available under GEO 
accession number GSE52628. For the present analysis, their positions 
were converted to mm10 using the UCSC (University of California, 
Santa Cruz) Genome Browser tool LiftOver; this file is available un-
der GEO accession number GSE144144.
DMC1 ChIP-seq
Two biological DMC1 ChIP replicates were performed with 
B6.Prdm9EP/EP males using a previously described method (17, 50). 
Briefly, testes from two euthanized adult mice (one per replicate) were 
removed, decapsulated, and cross-linked with 1% paraformaldehyde 
solution for 10 min. The tissue was homogenized and filtered with 
a 70-m cell strainer to obtain germ cells. Cells were washed with 
lysis buffer 1 [0.25% Triton X-100, 10 mM EDTA, 0.5 mM EGTA, 
and 10 mM tris-HCl (pH 8.0)] and lysis buffer 2 [0.2 M NaCl, 1 mM 
EDTA, 0.5 mM EGTA, and 10 mM tris-HCl (pH 8.0] and resus-
pended in lysis buffer 3 [1% SDS, 10 mM EDTA, and 50 mM tris-
HCl (pH 8.0)] with 1× protease inhibitor cocktail. The chromatin 
was then sheared to ∼1000 bp by sonication and dialyzed against 
ChIP buffer [0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM 
tris-HCl, (pH 8.0), and 167 mM NaCl] for at least 6 hours. Ten micro-
liters of chromatin were saved as input. The rest of the chromatin was 
incubated with an antibody against DMC1 (Santa Cruz, sc-8973) 
overnight at 4°C. The mixture was then incubated with Protein G 
Dynabeads (Thermo Fisher Scientific, 10004D) for 4 hours at 4°C. 
The beads were washed with wash buffer 1 [0.1% SDS, 1% Triton 
X-100, 2 mM EDTA, 20 mM tris-HCl, (pH 8.0), and 150 mM NaCl], 
wash buffer 2 [0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM 
tris-HCl, (pH 8.0), and 500 mM NaCl], wash buffer 3 [0.25 M LiCl, 
1% NP-40, 1 mM EDTA, 10mM tris-HCl, (pH 8.0), and 1% deoxy-
cholic acid] and twice with TE (Tris-EDTA) buffer. The chromatin 
was eluted with dilution buffer [1% SDS and 0.1 M NaHCO3 (pH 9.0)] 
at 65°C for 30 min and reverse–cross-linked by adding 200 mM 
NaCl and incubating overnight at 65°C. ChIP and input DNA were 
purified by the MinElute Reaction Cleanup Kit (Qiagen, 28006). For 
library preparation, DNA was first end-repaired by incubation with 
1× T4 DNA Ligase Reaction Buffer with 0.25 mM deoxynucleotide 
triphosphates (dNTPs) 3 U of T4 DNA polymerase (NEB, M0203S), 1 U 
of Klenow Enzyme [New England Biolabs, Inc. (NEB), M0210S], 
and 10 U of T4 PNK (NEB, B0202S) at 20°C for 30 min, followed 
by addition of 3′-A overhangs using Klenow Fragment 3′-5′ exo- 
(NEB, M0212S). After denaturation of DNA at 95°C for 3 min, 
adapters from the TruSeq Nano DNA LD Library Prep Kit (set A, 
Illumina, FC-121-4001) were ligated with a Quick Ligation kit 
(New England Biolabs (NEB), M2200S). The libraries then were 
amplified using polymerase chain reaction enhancer mix and 
primer cocktail (Illumina, FC-121-4001) for 12 cycles. For each 
step, DNA was purified by the MinElute Reaction Cleanup Kit. Li-
braries were sequenced on the Illumina NextSeq 500 platform, with 
75-bp paired-end reads.
DMC1 analysis
Fastq files for paired-end sequenced DMC1 samples were processed 
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paired-end sequenced DMC1 samples were trimmed using Trimmo-
matic (v0.32) and subsequently parsed for detection and selection 
of paired reads having homology at the 5′ and 3′ ends as established 
by protocols for single strand DNA enrichment. These selected 
paired-end reads represent the detectable single-stranded DNA reads. 
The microhomology sequence was removed from the read sequences, 
and they were subsequently aligned to the mm10 genome using 
BWA (v0.5.10-tpx). Bam files from this alignment were parsed for 
detection and subsequent selection of single-ended reads contain-
ing true genomic sequence versus fill-in sequence at the micro-
homologous region. Strandedness could be detected by the alignment 
flags, and no biases were found between strands. Fastq files were 
subsequently created containing only the Watson and Crick strand 
sequences and subsequently processed using nonpaired-end align-
ment pipelines. Peaks were called using MACS 2.0 with the read 
extension parameter set to 800 to force pileups.
This yielded 3,348,889 and 4,119,326 aligned DMC1 reads for the 
two B6.Prdm9EP/EP replicates, respectively. We merged these two rep-
licates for analysis, yielding 7,468,215 aligned DMC1 reads in the 
merged file. For comparison to wild type, we used previously re-
ported DMC1 sequence data from wild-type C57BL/6 N males (17). 
We merged three biological replicates for analysis; these replicates 
had 2,845,239, 2,938,318, and 5,108,836 aligned DMC1 reads, re-
spectively, yielding a merged file with 10,712,776 aligned DMC1 reads 
(GEO accession GSE112110; samples SRX3825301, SRX3825302, 
and SRX3825303).
Peak calling was performed using MACS (v.2.0) with standard 
treatment (ChIP) and control (input) samples with a false discovery 
rate value of 0.01. For an input sample, we used previously reported 
wild-type input data from C57BL/6 N males (17). For analysis, we 
merged two biological replicates, containing 13,651,687 and 11,604,547 
aligned reads, yielding a merged input file with 25,256,234 aligned 
reads (GEO accession GSE112110; samples SRX3825309 and 
SRX3825310). This input file was used as the peak calling control 
for both the wild-type and B6.Prdm9EP/EP merged ChIP files. Our 
set of PRDM9-independent DMC1 peaks is the set of peaks from 
Brick et al. (7) in which the authors performed DMC1 ChIP-seq in 
Prdm9-null mice (GEO accession GSE35498). We mapped this file 
to mm10 for our analysis; our remapped file is available at GEO 
accession GSE144144.
MA plots
To generate MA plots [M (log ratio) and A (mean average) Bland–
Altman plot], we first counted the number of sequencing reads within 
each peak using Bedtools (v2.27.0) coverage, using the -counts 
function with default parameters. We then normalized these counts 
to RPM mapped reads and used the normalized counts as input for 
MA plots. The actual plots were generated using the plotMA function 
of the R package limma (www.r-project.org/), with default parameters.
B6xWSB-Prdm9EP/EP crossover analysis
Wild-type WSB/EiJ males were crossed with B6.Prdm9+/EP hetero-
zygous females to generate B6WSBF1.Prdm9+/EP mice. These F1 mice 
were crossed together to produce B6WSBF2.Prdm9EP/EP homozygotes. 
Female B6WSBF2.Prdm9EP/EP homozygotes were then crossed to 
wild-type C57BL/6J males to generate ((B6xWSB)F2xB6)F3 back-
crossed progeny. Three B6xWSBF2.Prdm9EP/EP females and 20 of their 
((B6xWSB)F2xB6)F3 offspring were genotyped on the GigaMUGA 
SNP array. Crossovers were called on the basis of informative SNPs 
between B6 and WSB, using an in-house R script (available upon 
request). We defined a crossover as having at least five consecutive 
informative markers (markers differing in genotype between B6 and 
WSB) of the appropriate genotype on each side of the event. Cross-
over calls were confirmed using HaploQA—software developed at 
The Jackson Laboratory that calls crossovers based on a Hidden 
Markov Model. Individual chromosomes with more than five cross-
overs were excluded from analysis. Crossovers present in the mothers 
were subtracted from those in the offspring. The 94 informative 
offspring-specific crossover intervals were assessed for overlap with 
known hotspots—defined as PRDM9-dependent H3K4me3 peaks 
in the B6 genetic background (n = 18,838) (15)—using bedtools 
intersect (v2.27.0) with default parameters.
The WSB sequences (ENSEMBL) of crossover intervals with no 
B6 hotspot were searched for 11-bp PRDM9Dom2 binding motifs using 
the MEME suite tool FIMO. The PRDM9Dom2 motif table was based 
on the empirically determined consensus motif (19). The WSB and 
B6 motif lists were compared, and those WSB intervals with no novel 
PRDM9Dom2 binding motifs relative to the cognate B6 intervals were 
noted as such.
Testis extract preparation and Western blotting
Crude testis extract was prepared as reported previously (17) from 
12 dpp male mice with the denoted genotypes. Samples were sub-
jected to standard SDS–polyacrylamide gel electrophoresis and 
Western blotting for detection of PRDM9 (1:1000), using a guinea 
pig anti-PRDM9 antibody produced in-house (2). Subsequently, the 
blot was stripped and reprobed with mouse anti–-tubulin primary 
antibody (1:10,000, Sigma-Aldrich Cat# T4026). Primary antibodies 
were detected with horseradish peroxidase (HRP)–conjugated anti–
guinea pig (1:5000, Cat# AP193P) and HRP-conjugated anti-mouse 
secondary antibodies (1:20,000, Bio-Rad Cat# 170-6516), respectively.
Sequence alignment analysis
The DNA sequence for Rnf212 and Chk2 for mm10 reference, CAST/EiJ, 
and C57BL/6NJ was obtained from published sequence datasets 
at www.sanger.ac.uk/science/data/mouse-genomes-project and 
http://useast.ensembl.org/Mus_musculus/Info/Index. The alignment 
was performed using Blastn. Data were visualized using dot ma-
trix plots.
Quantification and statistical analysis
Statistical tests were performed using GraphPad Prism version 7.0 
and R statistical packages.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/43/eabb6606/DC1
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